Massachusetts pairs detailed Board of Registration in Medicine advertising rules with one of the most plaintiff-friendly consumer protection statutes in the country, Chapter 93A.
State-level overview
Massachusetts healthcare marketing compliance operates under the Board of Registration in Medicine (BORM), which enforces 243 CMR 2.07 advertising rules, and the Massachusetts AG's Chapter 93A authority. Chapter 93A is unusually broad and provides treble damages plus attorney fees, which makes Massachusetts a meaningful private-litigation jurisdiction for healthcare marketing in addition to AG enforcement.
BORM enforces 243 CMR 2.07, which restricts deceptive advertising, regulates testimonial use, requires substantiation for outcome claims, and limits guarantee language. Massachusetts has also been active on physician-owned corporate-entity marketing and on supervision representations in aesthetic practice.
The MA AG uses Chapter 93A authority - one of the broadest consumer protection statutes in the country - against deceptive healthcare marketing. Recent enforcement has included telehealth prescribing advertising, compounded medication marketing, and cosmetic practice pricing. Chapter 93A also permits private actions with treble damages and fees, creating significant class-action exposure.
Enforcement focus
Chapter 93A is the most plaintiff-friendly consumer protection statute in the US. Healthcare marketing that misleads consumers can face class actions with treble damages even where AG enforcement does not act.
BORM 243 CMR 2.07 has specific rules on testimonial use and on substantiation for outcome claims. Massachusetts has been active on aesthetic and weight-loss practice testimonials.
Massachusetts has heightened sensitivity to compounding-pharmacy marketing following the NECC tragedy. AG enforcement on compounded GLP-1 and related medication marketing has been notably active.
BORM enforces supervision rules for non-physician practitioners in aesthetic settings. Marketing implying independent practice is treated as a substantive disciplinary matter.
Patterns we flag in Massachusetts
Outcome guarantees in any medical advertising
Why: BORM rules and Chapter 93A both create substantial exposure.
Compounded GLP-1 brand-equivalence claims
Why: MA AG has been active on compounded medication marketing under Chapter 93A.
Testimonials without substantiation or typical-experience disclosure
Why: BORM 243 CMR 2.07 substantiation rules.
Telehealth marketing minimizing clinical evaluation
Why: MA AG and BORM both have authority on this pattern.
Nurse-injector independence representations
Why: BORM supervision enforcement.
By specialty
By specialty in Massachusetts
Specialty rules stack on top of state rules. Find the specialty-specific framework that applies to your practice.
Disclaimer
This summary reflects general patterns in Massachusetts healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Massachusetts-licensed healthcare marketing attorney.
RegenCompliance applies federal FDA and FTC rules plus the most-enforced state patterns automatically. Massachusetts-specific language is part of the rule set.
Other state guides
See allCalifornia healthcare marketing sits under the strictest state-level enforcement environment in the country - Medical Board of California rules, Business & Professions Code §17500 false advertising authority, and active AG consumer protection.
Read state guideTexas has an active Medical Board with specific rules for medical advertising, and the DTPA gives consumers and the state AG independent enforcement authority over deceptive healthcare marketing.
Read state guideFlorida's regulatory environment is defined by the Board of Medicine, FDUTPA, and an AG office that has been active on healthcare marketing - particularly in the fast-growing med spa, weight-loss, and regen categories.
Read state guide